BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24146440)

  • 1. Endothelium-independent and endothelium-dependent vasorelaxation by a dichloromethane fraction from Anogeissus Leiocarpus (DC) Guill. Et Perr. (Combretaceae): possible involvement of cyclic nucleotide phosphodiesterase inhibition.
    Belemnaba L; Ouédraogo S; Auger C; Chataigneau T; Traore A; Guissou IP; Lugnier C; Schini-Kerth VB; Bucher B
    Afr J Tradit Complement Altern Med; 2013; 10(2):173-9. PubMed ID: 24146440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-independent vasorelaxant effect of a Berberis orthobotrys root extract via inhibition of phosphodiesterases in the porcine coronary artery.
    Alamgeer ; Chabert P; Akhtar MS; Jabeen Q; Delecolle J; Heintz D; Garo E; Hamburger M; Auger C; Lugnier C; Kim HJ; Oak MH; Schini-Kerth VB
    Phytomedicine; 2016 Jul; 23(8):793-9. PubMed ID: 27288914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-dependent and -independent vasorelaxation by a theophylline derivative MCPT: roles of cyclic nucleotides, potassium channel opening and phosphodiesterase inhibition.
    Lo YC; Tsou HH; Lin RJ; Wu DC; Wu BN; Lin YT; Chen IJ
    Life Sci; 2005 Jan; 76(8):931-44. PubMed ID: 15589969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel.
    Lugnier C; Keravis T; Eckly-Michel A
    J Physiol Pharmacol; 1999 Dec; 50(4):639-52. PubMed ID: 10639014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An aqueous extract of the Anogeissus leiocarpus bark (AEAL) induces the endothelium-dependent relaxation of porcine coronary artery rings involving predominantly nitric oxide.
    Belemnaba L; Ouédraogo S; Nitiéma M; Chataigneau T; Guissou IP; Schini-Kerth VB; Bucher B; Auger C
    J Basic Clin Physiol Pharmacol; 2018 Nov; 29(6):599-608. PubMed ID: 29723154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tambulin is a major active compound of a methanolic extract of fruits of Zanthoxylum armatum DC causing endothelium-independent relaxations in porcine coronary artery rings via the cyclic AMP and cyclic GMP relaxing pathways.
    Mushtaq MN; Ghimire S; Alamgeer ; Akhtar MS; Adhikari A; Auger C; Schini-Kerth VB
    Phytomedicine; 2019 Feb; 53():163-170. PubMed ID: 30668395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells.
    Mercapide J; Santiago E; Alberdi E; Martinez-Irujo JJ
    Biochem Pharmacol; 1999 Nov; 58(10):1675-83. PubMed ID: 10535760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.
    Prieto D; Simonsen U; Hernández M; García-Sacristán A
    Br J Pharmacol; 1998 Apr; 123(8):1609-20. PubMed ID: 9605568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue.
    Gonçalves RL; Lugnier C; Keravis T; Lopes MJ; Fantini FA; Schmitt M; Cortes SF; Lemos VS
    Eur J Pharmacol; 2009 Oct; 620(1-3):78-83. PubMed ID: 19686719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
    Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
    Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
    Birk S; Edvinsson L; Olesen J; Kruuse C
    Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.
    Yao M; Roberts DD; Isenberg JS
    Pharmacol Res; 2011 Jan; 63(1):13-22. PubMed ID: 20971192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic smooth muscle relaxants KMUP-3 and KMUP-4, two nitrophenylpiperazine derivatives of xanthine, display cGMP-enhancing activity: roles of endothelium, phosphodiesterase, and K+ channel.
    Wu BN; Chen IC; Lin RJ; Chiu CC; An LM; Chen IJ
    J Cardiovasc Pharmacol; 2005 Nov; 46(5):600-8. PubMed ID: 16220066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of visnagin on cyclic nucleotide phosphodiesterases and their role in its inhibitory effects on vascular smooth muscle contraction.
    Duarte J; Lugnier C; Torres AI; Pérez-Vizcaino F; Zarzuelo A; Tamargo J
    Gen Pharmacol; 1999 Jan; 32(1):71-4. PubMed ID: 9888257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty.
    Zhao H; Quilley J; Montrose DC; Rajagopalan S; Guan Q; Smith CJ
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2973-81. PubMed ID: 17293498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N; Lugnier C; Stoclet JC
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NO-cGMP pathway and potassium channels on the relaxation induced by clonidine in the rat mesenteric arterial bed.
    Pimentel AM; Costa CA; Carvalho LC; Brandão RM; Rangel BM; Tano T; Soares de Moura R; Resende AC
    Vascul Pharmacol; 2007 May; 46(5):353-9. PubMed ID: 17258511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.